Cantor Fitzgerald Maintains Varonis Systems (VRNS) Overweight Recommendation

Cantor Fitzgerald maintained an Overweight rating for Varonis Systems (VRNS) on October 24, 2025, with an average analyst price target of $62.08, implying a marginal 0.33% downside from its current $62.29. The company anticipates annual revenue of $635 million, a 6.71% increase, and non-GAAP EPS of $0.47. Despite a 2.44% decrease in total institutional shares owned and a slight reduction in the number of institutional holders, the average portfolio weight dedicated to VRNS increased by 9.78%, alongside a bullish put/call ratio of 0.75, indicating mixed but generally positive sentiment among investors.

Analysis

Cantor Fitzgerald maintained an "Overweight" rating for Varonis Systems (VRNS) on October 24, 2025, despite an average one-year price target of $62.08 suggesting a marginal 0.33% downside from its current $62.29 closing price. This target, however, falls within a wide forecast range of $27.27 to $84.00, indicating varied analyst perspectives on future valuation. The company projects annual revenue of $635 million, marking a 6.71% increase, alongside a non-GAAP EPS of $0.47.

Institutional ownership data presents a mixed picture, with the number of funds reporting positions decreasing by 0.44% (3 owners) and total shares owned by institutions declining 2.44% to 144,548K shares. Conversely, the average portfolio weight dedicated to VRNS by these funds increased by 9.78%, suggesting higher conviction among remaining or new holders. The put/call ratio of 0.75 further indicates a bullish outlook among options traders.

Individual institutional actions highlight this divergence, with Goldman Sachs significantly reducing its VRNS holdings by 7.42% and decreasing portfolio allocation by 75.36%. In contrast, Vanguard Total Stock Market Index Fund (VTSMX), First Trust Advisors, and Soma Equity Partners all increased their share counts and portfolio allocations, demonstrating continued or growing confidence in the stock.

Key Decisions for Investors

• Monitor the divergence in institutional positioning, particularly the significant reduction by Goldman Sachs against increases by other major funds, to understand evolving conviction.
• Evaluate the "Overweight" rating in conjunction with the implied 0.33% downside from the average price target, considering the wide forecast range and the company's projected revenue growth of 6.71%.
• Consider the bullish put/call ratio of 0.75 as a positive sentiment indicator, but balance it against the slight decrease in total institutional shares owned, suggesting a nuanced market view.